This 52-week high and low NAV tracker follows Indian mutual funds whose latest NAV crossed its prior 52-week high or low. Fund names link to the full fund page with holdings and returns. Funds tagged NEW have under 6 months of history. · Data as of 16 Jul 2026
| Fund | Category | Age | Current NAV | 52W High NAV | Distance from High |
|---|---|---|---|---|---|
| Nippon India Nifty Pharma ETF Nippon India Mutual Fund | Index/ETF | 3+ years | 0% below high | ||
| Edelweiss Multi Asset Allocation Fund - Direct Plan - Growth Edelweiss Mutual Fund | Multi Asset | 3+ years | 0% below high | ||
| SBI MIDCAP FUND - DIRECT PLAN - GROWTH SBI Mutual Fund | Mid Cap | 3+ years | 0.01% below high | ||
| ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth ICICI Prudential Mutual Fund | Index/ETF | 3+ years | 0.01% below high | ||
| ITI Pharma and Healthcare Fund - Direct Plan - Growth Option ITI Mutual Fund | Equity | 3+ years | 0.01% below high | ||
| Motilal Oswal Nifty MidSmall Healthcare Index Fund- Direct Plan-Growth Motilal Oswal Mutual Fund | Index/ETF | 1 year 7 months | 0.01% below high | ||
| Tata Nifty MidSmall Healthcare Index Fund - Direct Plan - Growth Tata Mutual Fund | Index/ETF | 2 years 2 months | 0.02% below high | ||
| IB52-Groww Nifty Smallcap 250 ETF Groww Mutual Fund | Index/ETF | < 1 month NEW | 0.03% below high | ||
| Union Large & Midcap Fund - Direct Plan - Growth Option Union Mutual Fund | Mid Cap | 3+ years | 0.03% below high | ||
| BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTH Bajaj Finserv Mutual Fund | Equity | 1 year 6 months | 0.04% below high | ||
| Tata India Innovation Fund- Direct Growth Tata Mutual Fund | Equity | 1 year 7 months | 0.04% below high | ||
| Franklin India Multi Cap Fund - Direct - Growth Franklin Templeton Mutual Fund | Multi Cap | 1 year 11 months | 0.05% below high | ||
| Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth Aditya Birla Sun Life Mutual Fund | Equity | 3+ years | 0.05% below high | ||
| Mirae Asset Nifty 50 Index Fund Mirae Asset Mutual Fund | Index/ETF | 3+ years | 0.06% below high | ||
| quant Momentum Fund - Growth Option - Direct Plan Quant Mutual Fund | Equity | 2 years 7 months | 0.06% below high | ||
| quant Large Cap Fund - Growth Option - Direct Plan Quant Mutual Fund | Large Cap | 3+ years | 0.06% below high | ||
| Invesco India Manufacturing Fund - Direct Plan - Growth Invesco Mutual Fund | Equity | 1 year 10 months | 0.09% below high | ||
| Abakkus Flexi Cap Fund - Direct - Growth Abakkus Mutual Fund | Flexi Cap | 6 months | 0.09% below high | ||
| quant ELSS Tax Saver Fund - Growth Option - Direct Plan Quant Mutual Fund | ELSS | 3+ years | 0.09% below high | ||
| Kotak Special Opportunities Fund - Direct Plan - Growth Option Kotak Mutual Fund | Equity | 2 years | 0.1% below high | ||
| quant Mid Cap Fund - Growth Option - Direct Plan Quant Mutual Fund | Mid Cap | 3+ years | 0.11% below high | ||
| HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan HDFC Mutual Fund | Equity | 2 years 9 months | 0.14% below high | ||
| Motilal Oswal Consumption Fund-Direct-Growth Motilal Oswal Mutual Fund | Equity | 8 months | 0.14% below high | ||
| quant ESG Integration Strategy Fund Quant Mutual Fund | Equity | 3+ years | 0.19% below high | ||
| Abakkus Small Cap Fund - Direct Plan - Growth Abakkus Mutual Fund | Small Cap | 3 months NEW | 0.22% below high | ||
| Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option Nippon India Mutual Fund | Equity | 3+ years | 0.23% below high | ||
| HDFC Manufacturing Fund HDFC Mutual Fund | Equity | 2 years 2 months | 0.24% below high | ||
| Tata India Pharma & Healthcare Fund-Direct Plan-Growth Tata Mutual Fund | Equity | 3+ years | 0.28% below high | ||
| Groww Nifty Chemicals ETF Groww Mutual Fund | Index/ETF | 6 months | 0.3% below high | ||
| Kotak Nifty Chemicals ETF Kotak Mutual Fund | Index/ETF | 7 months | 0.3% below high | ||
| Aditya Birla Sun Life Manufacturing Equity Fund - Direct Plan - Growth Aditya Birla Sun Life Mutual Fund | Equity | 3+ years | 0.31% below high | ||
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH SBI Mutual Fund | Equity | 3+ years | 0.32% below high | ||
| UTI Healthcare Fund - Direct Plan - Growth Option UTI Mutual Fund | Equity | 3+ years | 0.35% below high | ||
| quant Healthcare Fund - Growth Option - Direct Plan Quant Mutual Fund | Equity | 2 years 11 months | 0.36% below high | ||
| SBI Long Term Advantage Fund - Series V - Direct Plan - Growth SBI Mutual Fund | Equity | 3+ years | 0.38% below high | ||
| Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth Edelweiss Mutual Fund | Equity | 3+ years | 0.39% below high | ||
| SBI Quality Fund - Direct Plan - Growth SBI Mutual Fund | Equity | 4 months NEW | 0.51% below high | ||
| quant Focused Fund - Growth Option-Direct Plan Quant Mutual Fund | Focused | 3+ years | 0.59% below high | ||
| quant Manufacturing Fund - Growth Option - Direct Plan Quant Mutual Fund | Equity | 2 years 11 months | 0.61% below high | ||
| SBI MNC FUND - DIRECT PLAN -GROWTH SBI Mutual Fund | Equity | 3+ years | 0.62% below high | ||
| Motilal Oswal Innovation Opportunities Fund - Direct Plan- Growth Motilal Oswal Mutual Fund | Equity | 1 year 4 months | 0.62% below high | ||
| Kotak Manufacture in India Fund - Direct Plan Growth Kotak Mutual Fund | Equity | 3+ years | 0.75% below high | ||
| DSP Healthcare Fund - Direct Plan - Growth DSP Mutual Fund | Equity | 3+ years | 0.79% below high |
When a mutual fund's NAV is trading within a small percentage of its 52-week high, it signals that the fund has held on to most of its gains over the past year without a significant drawdown. In stock market analysis, a security trading near its 52-week high is considered to be showing price momentum — the same principle applies to mutual fund NAVs. A fund at 3% below its 52-week high has experienced almost no meaningful correction in a year; a fund at 18% below has given back a significant portion of its gains.
The distance from 52-week high is calculated as: ((52-week high NAV − current NAV) / 52-week high NAV) × 100. The lower this number, the closer the fund is to its peak — and the stronger its recent momentum. This screener lets you set a threshold of 5%, 10%, 15% or 20% and filter further by category, so you can compare momentum within a peer group rather than across categories with different return profiles.
Academic research across equity markets has consistently documented a momentum effect — securities that have performed well over the past 6 to 12 months tend to continue outperforming over the following months. This effect has been observed in stocks, bonds and commodities, and a growing body of evidence suggests it holds for mutual fund NAVs as well.
For practical investors, this screener answers a specific question: among the hundreds of mutual fund schemes available in India, which ones are currently showing the strongest relative performance within their category? A Small Cap fund that is within 5% of its 52-week high while peers are 20 to 30% below theirs is demonstrating meaningful outperformance — it deserves to be on a watchlist for further research, even if the screener itself does not tell you whether to buy it.
Funds tagged NEW on this page have less than 6 months of NAV history. For such funds, being near a 52-week high simply means they have not had enough time to experience a correction — it carries no momentum signal. Focus on funds with at least 1 to 3 years of history when using this screener.
If you already hold a mutual fund, checking whether it is near its 52-week high is a quick health check. A fund that is consistently near its high while its category peers are pulling back is likely outperforming on a relative basis — a sign that the fund manager's positioning is working. Conversely, a fund that has fallen significantly from its 52-week high while peers remain near theirs may warrant a closer look at what has changed in the portfolio.
For new investments, this screener is a starting point, not a destination. A fund near its 52-week high has shown recent strength, but you still need to evaluate its 3-year and 5-year CAGR versus the category average, its consistency across market cycles, the fund manager's track record, and whether the category itself aligns with your investment horizon and risk appetite. This page provides analytical data only and does not constitute investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.